Registration Closed
Credit Types:
AMA PRA Category 1™
(21.0),
ABIM MOC
(21.0),
ABIM MOC (21),
Price: $650 - $780
Thursday, March 30, 2017 |
||
6:30 a.m. | Registration and Continental Breakfast | |
7:00 a.m. | Welcome Haraldur Bjarnason, M.D. and Raymond C. Shields, M.D. |
|
Session I - Thoracic Aortic Disease
|
||
7:05 a.m. |
Advances in CT Aortic Imaging: Latest Trends and Future Developments |
|
7:20 a.m. | Acute Uncomplicated Type B Aortic Dissection: Who Benefits Most from TEVAR? Randall R. DeMartino, M.D. |
|
7:35 a.m. |
Open Surgical Repair in Young Patients and Those with Genetically Triggered Aortic Disease |
|
7:50 a.m. | Branched Endografts for Treatment of Thoracoabdominal Aortic Aneurysms Gustavo S. Oderich, M.D. |
|
8:05 a.m. |
Strategies to Minimize Risk of Spinal Cord Injury During Complex Endovascular Aortic Repair Gustavo S. Oderich, M.D. |
|
8:20 a.m. | Panel Discussion | |
8:35 a.m. | Refreshment Break | |
Peripheral Arterial Disease
|
||
8:50 a.m. |
Buttock TcPO2s: What is it About and When to Use It (Don’t Take It Sitting Down) Paul W. Wennberg, M.D. |
|
9:05 a.m. |
CLEVER Trial and Beyond: Updates on PAD Fadi E. Shamoun, M.D. |
|
9:20 a.m. |
Gender Differences in PAD: Is it Real and What to do About It? TBD |
|
9:35 a.m. |
Diabetic Peripheral Arterial Disease: Current Recommendations and Best Practices Fadi E. Shamoun, M.D. |
|
9:50 a.m. |
Statins, PCSK9 Inhibitors and Ezetimide: Impact on PAD Management in the Future Iftikhar J. Kullo, M.D. |
|
10:05 a.m. |
Perioperative Cardiac Risk Management for Vascular Surgery: Update and Latest Guidelines TBD |
|
10:20 a.m. |
Upper Extremity Arterial Disease: Unforgettable Cases and Latest Developments Roger F. Shepherd, M.B., B.Ch |
|
10:35 a.m. | Rapid Fire Abstract Presentations | |
10:45 a.m. | Panel Discussion | |
11:00 a.m. | Break to Retrieve Lunch | |
11:15 a.m. | Lunch Session: Munch While You Learn Genomics of PAD: How Genomics Can Be Applied to the Vascular Practice of the Future Iftikhar J. Kullo, M.D. |
|
11:45 a.m. | Break | |
Unusual Vascular Diseases and Intervention
|
||
12:00 p.m. |
Unsual Arteriopathies: FMD, Segmental Arterial Mediolysis, and Spontaneous Dissections Gregory W. Barsness, M.D. |
|
12:15 p.m. |
Pelvic Congestion Syndrome: What to Look for and How to Treat Melissa J. Neisen, M.D. |
|
12:30 p.m. |
PVD in Athletes: What to Look Out For Kevin P. Cohoon, D.O. |
|
12:45 p.m. |
Cases in Prediction, Prevention, and Management of Perioperative Cardiac Complications During Vascular Surgery Gregory W. Barsness, M.D. |
|
1:00 p.m. | Refreshment Break | |
Session II – Abdominal Aortic Disease
|
||
1:15 p.m. |
Perspectives of Three Decades of Experience with Open and Endovascular Repair of Infrarenal Abdominal Aortic Aneurysms at Mayo Clinic: Current Recommendations Peter Gloviczki, M.D. |
|
1:30 p.m. |
Results of Open and Endovascular Repair of Inflammatory Aneurysms William M. Stone, M.D. |
|
1:45 p.m. |
Endotension and Endoleaks: Best Management Strategies and Outcomes Randall R. DeMartino, M.D. |
|
2:00 p.m. |
Who Needs Open Aortic Reconstruction for Occlusive Disease in the Endovascular Era? William M. Stone M.D. |
|
2:15 p.m. |
Expanding Indications of Endovascular and Hybrid Repair to TASC D Iliac Lesions Samuel R. Money, M.D. |
|
2:30 p.m. |
Robotic Assisted Procedures in Vascular Surgery Samuel R. Money, M.D. |
|
2:45 p.m. | Rapid Fire Abstract Presentations | |
2:55 p.m. | Panel Discussion | |
3:15 p.m. |
Workshop Option 1: Paul W. Wennberg, M.D. and David A. Liedl, R.N. |
|
Workshop Option 2: |
||
4:15 p.m. | Adjourn | |
6:30 - 8:30 p.m. | Course Reception for faculty, attendees, and guests | |
|
||
Lower Extremity Arterial Intervention
|
||
6:30 a.m. | Continental Breakfast | |
7:00 a.m. |
Atherectomy, Laser, and Other Devices in PAD: Should We Expect a Different Result than the Coronary Circulation? Gregory W. Barsness, M.D. |
|
7:15 a.m. |
Benefits and Risks of Antiplatelet/Anticoagulation Therapy and Combinations Following Peripheral Intervention: If I Were Writing the Guidelines… Robert D. McBane, M.D. |
|
7:30 a.m. |
DCB and DES for Atherosclerotic Disease Eric H. Yang, M.D. |
|
7:45 a.m. |
New Techniques in Approaching SFA and Infrapopliteal Disease Arashk Motiei, M.D. |
|
8:00 a.m. |
Rapid Fire Abstract Presentations |
|
8:10 a.m. | Panel Discussion | |
8:25 a.m. | Refreshment Break | |
Endovascular and Open Surgical Treatment of PAD
|
||
8:40 a.m. |
Advances in PAD Imaging: Seeing Past the Calcified Plaque Terri J. Vrtiska, M.D. |
|
8:55 a.m. |
Infrapopliteal Endovascular Interventions for Critical Limb Ischemia: Where are the Latest Trials Leading Us? Sanjay Misra, M.D. |
|
9:10 a.m. |
Combined Open Surgical and Endovascular Management of Lower Extremity Arterial Occlusive Disease: Current Practice and Outcomes Thomas C. Bower, M.D. |
|
9:25 a.m. |
Robotic-Assisted Peripheral Vascular Intervention: Current Data and Trends Sanjay Misra, M.D. |
|
9:40 a.m. | Panel Discussion | |
Vascular Malformation and Fibromuscular Dysplasia
|
||
10:00 a.m. |
Vascular Malformation: Imaging Haraldur Bjarnason, M.D. |
|
10:15 a.m. |
Vascular Malformation: Treatment Algorithms Haraldur Bjarnason, M.D. |
|
10:30 a.m. |
Spontaneous Coronary Artery Dissection: An Update for the Vascular Specialist Arashk Motiei, M.D. |
|
10:45 a.m. |
An Update on Fibromuscular Dysplasia Kevin P. Cohoon, D.O. |
|
11:00 a.m. | Panel Discussion | |
11:15 a.m. | Break to Retrieve Lunch | |
11:30 a.m. |
Lunch Session: Munch While You Learn Updates in Vascular Wound Management: Wound Management in the Age of Regenerative Medicine Karen L. Andrews, M.D. |
|
12:00 p.m. | Break | |
Venous Thromboembolism
|
||
12:15 p.m. |
Anticoagulation Therapy for Cancer Related Acute Venous Thromboembolism: Best Options and Current Recommendations Robert D. McBane, M.D. |
|
12:30 p.m. |
Prevention of Post-Phlebitic Syndrome: Adjuncts for the Treatment of Acute DVT Thom W. Rooke, M.D. |
|
12:45 p.m. |
Acute Pulmonary Embolism: PERTS and Squirts, Who Should Undergo Thrombolysis and How? Raymond C. Shields, M.D. |
|
1:00 p.m. |
Where Are We Now With IVC Filters Haraldur Bjarnason, M.D. |
|
1:15 p.m. |
Panel Discussion |
|
1:30 p.m | Refreshment Break | |
Chronic Venous Disease: Surgical and Endovascular Management
|
||
1:45 p.m. |
Surgical and Endovenous Treatment for Ilio-Femoral Venous Occlusions: What are the Current Outcomes and Best Practices? Melissa J. Neisen, M.D. |
|
2:00 p.m |
Endovascular Recanalization of Iliac Vein and IVC Occlusion: Best Approaches and Clinical Outcomes Haraldur Bjarnason, M.D. |
|
2:15 p.m. |
Sclerotherapy for Varicose Veins and Chronic Venous Insufficiency: Latest Techiques and Outcomes Thom W. Rooke, M.D. |
|
2:30 p.m. |
Compression Therapy for Venous Thromboembolic Disease: Is it Beneficial and What are the Current Guideline Recommendations? Kevin P. Cohoon, D.O. |
|
2:45 p.m. |
Rapid Fire Abstract Presentations |
|
2:55 p.m. | Panel Discussion | |
3:15 p.m. |
Workshop Option 1: Juan M. Bowen, M.D. |
|
Workshop Option 2: |
||
4:15 p.m. | Adjourn | |
|
||
6:30 a.m. | Continental Breakfast | |
Renal Vascular Disease and Hypertension
|
||
7:00 a.m. |
Renal Artery Endovascular Therapy and What is the Coral Trial Up To: Where to go From Here Stephen C. Textor, M.D. |
|
7:15 a.m. |
Hypertension: Updated Guidelines and Recommendations – How Low Should We Go and Why? Roger F. Shepherd, M.B., B.Ch. |
|
7:30 a.m. |
Catheter-Based Renal Artery Denervation: Any Hope for this Modality in the Future? Gregory W. Barsness, M.D. |
|
7:45 a.m. |
Indications and Results of Surgical Reconstructions for Renal Artery Disease at Mayo Clinic |
|
8:00 a.m. |
Hypertension Management in Acute Aortic Syndromes: Pearls and Pitfalls Stephen C. Textor, M.D. |
|
8:15 a.m. |
Rapid Fire Abstract Presentations |
|
8:25 a.m. | Panel Discussion | |
8:45 a.m. | Refreshment Break | |
Carotid Disease
|
||
9:00 a.m. |
Symptomatic Carotid Stenosis in 2017: An Update on Recent Trials - CEA or CAS and for Whom Richard J. Fowl, M.D. |
|
9:15 a.m. |
CREST-2: Trail Updates and What to Expect of Medical Management of Asymptomatic Carotid Disease? Thomas G. Brott, M.D. |
|
9:30 a.m. |
Subgroups Best Suited for Carotid Stenting: An Update and Best Practices Albert G. Hakaim, M.D. |
|
9:45 a.m. |
Why CEA Remains Preferred for Asymptomatic High-Grade Carotid Stenosis? Peter Gloviczki, M.D. |
|
10:00 a.m. |
Panel Discussion |
|
10:15 a.m. |
Carotid Atherosclerotic Disease and Cognitive Impairment: Should this be Routinely Screened? Thomas G. Brott, M.D. |
|
Cerebrovascular Disease and Stroke
|
||
10:30 a.m. |
Changing Epidemiology of Stroke: Why are National Rates Lower? Raymond C. Shields, M.D. |
|
10:45 a.m. |
Atrial Appendage Occlusive Devices: Who Benefits and When Should They be Used? Eric H. Yang, M.D. |
|
11:00 a.m. |
Non-Valvular Atrial Fibrillation: Based on CHADS-VASC Scores and Current Therapy, Who Should not be on Anticoagulation Therapy? Robert D. McBane, M.D. |
|
11:15 a.m. |
Whirlwind Tour of Recent Trials on Endovascular Stroke Therapy (MR CLEAN, ESCAPE, SWIFT PRIME, EXTEND IA, and REVASCAT) and Their Impact on Guideline Recommendations Thomas G. Brott, M.D. |
|
11:30 a.m. |
Periopertive Management of Novel Anticoagulants for Atrial Fibrillation: An Update on Strategies to Minimize Risk Fadi E. Shamoun, M.D. |
|
11:45 a.m. | Panel Discussion | |
12:00 p.m. | Closing Remarks | |
12:05 p.m. |
Adjourn |
Price: $650 - $780